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Background: The pathogenesis of caseonecrotic lesions developing in lungs and joints of calves infected with
Mycoplasma bovis is not clear and attempts to prevent M. bovis-induced disease by vaccines have been largely
unsuccessful. In this investigation, joint samples from 4 calves, i.e. 2 vaccinated and 2 non-vaccinated, of a
vaccination experiment with intraarticular challenge were examined. The aim was to characterize the histopathological
findings, the phenotypes of inflammatory cells, the expression of class II major histocompatibility complex (MHC
class II) molecules, and the expression of markers for nitritative stress, i.e. inducible nitric oxide synthase (iNOS) and
nitrotyrosine (NT), in synovial membrane samples from these calves. Furthermore, the samples were examined for
M. bovis antigens including variable surface protein (Vsp) antigens and M. bovis organisms by cultivation techniques.
Results: The inoculated joints of all 4 calves had caseonecrotic and inflammatory lesions. Necrotic foci were
demarcated by phagocytic cells, i.e. macrophages and neutrophilic granulocytes, and by T and B lymphocytes.
The presence of M. bovis antigens in necrotic tissue lesions was associated with expression of iNOS and NT by
macrophages. Only single macrophages demarcating the necrotic foci were positive for MHC class II. Microbiological
results revealed that M. bovis had spread to approximately 27% of the non-inoculated joints. Differences in extent
or severity between the lesions in samples from vaccinated and non-vaccinated animals were not seen.
Conclusions: The results suggest that nitritative injury, as in pneumonic lung tissue of M. bovis-infected calves, is
involved in the development of caseonecrotic joint lesions. Only single macrophages were positive for MHC class II
indicating down-regulation of antigen-presenting mechanisms possibly caused by local production of iNOS and NO by
infiltrating macrophages.
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Caseonecrotic pneumonia in calves and cattle is consid-
ered a distinctive lesion caused by Mycoplasma bovis [1].
In animals with pneumonia caused by M. bovis arthritis
frequently develops secondary to respiratory infection [2].
Within the joint tissue of M. bovis infected animals, as in
lungs, necrotic alterations occur [2–5]. The pathogenesis
of necrotizing joint lesions is not clear. Recent findings in
necrotic lung foci suggest that the production of nitric
oxide (NO) and peroxynitrite by inducible nitric oxide
(iNOS)- and nitrotyrosine (NT)-expressing macrophages
is potentially involved in the development of these tissue
lesions [6–8]. Furthermore, findings in necrotic lung tissue
of such calves indicate that surface protein antigen vari-
ation of M. bovis occurs in vivo and that local antigen-
presenting mechanisms are possibly down-regulated due
to the production of iNOS and NO [6,7,9].
Several efforts have been undertaken to develop vaccines
to prevent M. bovis induced disease. Certain vaccines give
partial protection from respiratory disease and reduce the
spread of M. bovis to internal organs including the joints
but other attempts have largely been unsuccessful [10]. A
deeper knowledge of the morphological changes due to M.
bovis in joint tissue may help to understand better the
mechanisms of the disease and may be a basis for future
interventions such as development of drugs or improved
vaccines.
In the present investigation, joint tissue samples from
2 vaccinated and 2 non-vaccinated calves of a vaccin-
ation experiment were examined by applying histological
and immunohistochemical techniques. One aim of this
study was to characterize the histopathological findings
and the types of inflammatory cells, the MHC class II
expression, and the expression of markers for nitritative
stress, i.e. iNOS and NT in samples from the inoculated
joint and several non-inoculated joints of the 4 calves. A
second aim was to examine the joint samples both for
the presence of M. bovis antigens including variable sur-
face protein (Vsp) antigens and for M. bovis organisms.
Methods
Calves and inoculation
In this study, 48 synovial membrane samples from 4M.
bovis-inoculated calves were examined. The calves had
been injected intraarticularly in an inoculation study de-
scribed elsewhere, which was performed to evaluate the
potential of a formalinized vaccine for prevention of M.
bovis arthritis [11] by following a previously used infection
protocol [12]. The animal experiment was conducted dur-
ing the years 1991–1992 in a registered facility of the gov-
ernmental institution Anses, UMR Mycoplasmoses des
Ruminants, Lyon Laboratory, Lyon, France. The animals
were kept in registered holding rooms for cattle and all
stages of the experimental protocol were performed andsupervised by certified veterinarians. These experiments
were carried out by veterinarians under the authority of
the French government. Briefly, the experiment was car-
ried out with 22 conventionally reared calves, aged be-
tween 8 and 15 days. All calves were examined for the
presence of antibodies to M. bovis by an indirect haem-
agglutination test [13]. None of the animals had sero-
logical evidence of previous exposure to M. bovis as
proved by 4 successive negative blood samplings at 8 days
intervals before the beginning of the experiment. At the
age of 4 to 5 weeks, eleven calves were vaccinated intra-
muscularly with 5 × 1010 formalin-inactivated M. bovis or-
ganisms with aluminium hydroxyde and Quail A saponine
as adjuvants (50:50) and 4 weeks later, a second vaccin-
ation with the same dose of the same vaccine was per-
formed. For production of the vaccine and for challenging
the animals M. bovis strain 1067, which had been isolated
from a cow with mastitis [14], was used. Three weeks after
the second vaccination, the 11 vaccinated calves and 10
non-vaccinated calves were challenged by inoculating
0.5 ml of culture medium containing 2.5 × 107 viable or-
ganisms of M. bovis into the joint space of the right carpal
joint. At challenge, the 21 calves were 11 to 12 weeks old.
Another calf (No. 5), which served as control, was inocu-
lated into the joint space of the right carpal joint with the
same volume of sterile Mycoplasma culture medium.
Before intraarticular inoculation, sedation and analgesia
were performed by intramuscular injection of 0.1 mg/kg
xylazine (Rompun, Bayer Santé-Division Santé Animale).
Serum samples from all animals were screened weekly
throughout the experiment for antibodies to M. bovis by
using a passive haemagglutination test [13].
Necropsy and sampling
One vaccinated and one non-vaccinated calf were eutha-
nized daily by injection of embutramide, mebezonium
iodide, and tetracaine hydrochloride (T61®, MSD Santé
Animale) and necropsied from day 10 after intraarticular
inoculation. Euthanasia and necropsy of the control calf
were carried out 13 days after intraarticular injection of
sterile culture medium. Synovial membrane samples
were collected from both fore limbs (elbow, carpal, and
metacarpo-phalangeal joints) and from both hind limbs
(femoro-tibial, tarsal, and metatarso-phalangeal joints).
The samples were analyzed for the presence of myco-
plasmas by standard cultivation procedures. Additional
samples from all joints were fixed in 10% neutral buff-
ered formalin and embedded in paraffin wax, sectioned
(4 μm) and stained with haematoxylin and eosin (H&E).
In the present investigation, samples from 2 vaccinated
calves and from 2 non-vaccinated calves from the vaccin-
ation experiment with subsequent intra-articular challenge
were randomly selected. They had been necropsied be-
tween days 10 and 14 after intraarticular inoculation with
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joint samples were examined. Furthermore, 12 samples
from the same joints of the control calf were examined.
Antibodies and immunohistochemistry
Paraffin sections were examined for M. bovis antigens,
calprotectin (S100A8 and S100A9)-expressing macro-
phages, MHC class II antigen, iNOS and NT by applying
the avidin-biotin-peroxidase (ABC) method and anti-
bodies as shown in Table 3. Following dewaxing and
blocking of endogenous peroxidase activity sections were
pretreated for antigen retrieval (Table 3). All primary
antibodies were incubated for approximately 16–18 h at
4°C. Thereafter, sections were incubated with biotin-
conjugated antibodies to rabbit IgG or mouse IgG or
IgM. For reactions with the monoclonal antibody (mAb)
pool, a mixture (1:1) of secondary biotin-conjugated
antibodies to mouse IgG and mouse IgM (each diluted
1:200) was used. After incubation with the ABC solution,
the chromogen AEC was used for sections incubated
with antibodies to iNOS and NT, for the other sections
DAB was applied. Counterstaining was performed with
Mayer’s haematoxylin. As positive controls for detecting
M. bovis antigen lung sections from a calf from another
experiment, which had been euthanised after respiratory
infection with M. bovis strain 1067, were used. Sections
of normal bovine lymph node tissue served as positive
controls for immunolabelling of T and B lymphocytes,
macrophages, and MHC class II antigen. As positive
control for labelling of iNOS and NT, lung sections from
normal cattle were used.
Results
Clinical and microbiological findings
The findings for all 22 calves of the vaccination experi-
ment were described previously [11]. Briefly, all 21M.
bovis-inoculated animals developed arthritis at the inocu-
lation site and became lame and recumbent. Subsequently,
most of the large joints became markedly swollen. From
all inoculated calves, M. bovis was reisolated from theTable 1 Microbiological findings in synovial tissue samples of
Mycoplasma bovis




1h 12 + + -
2h 14 - + -
3i 10 + + -
4i 12 - + -
aelbow joint. bcarpal joint. cinoculated joint. dmetacarpo-phalangeal joint.
efemoro-tibial joint. ftarsal joint. gmetatarso-phalangeal joint.
hnon-vaccinated animal. i vaccinated animal.
+isolation of M. bovis positive.
-isolation of M. bovis negative.right carpal joint. Bacteria other than M. bovis were not
isolated from any of the joints. In samples of the control
calf neither M. bovis organisms nor other bacteria were
detected by cultivation. Cultivation of joint samples re-
vealed that M. bovis was present in joint tissue samples of
8 of the 10 non-vaccinated calves and in 5 of the 11 vacci-
nated calves. Vaccinated calves showed a significant in-
crease of antibodies to M. bovis before challenge. The
difference between the number of M. bovis-infected joints
after challenge between the groups of vaccinated and non-
vaccinated animals was not statistically significant (Fisher’s
Exact Test). On necropsy, except from the joints, no gross
lesions were found in the lungs or any other organs.
Microbiological, histopathological and
immunohistochemical findings in synovial tissue samples
From a total of 44 non-inoculated joints from 2 non-
vaccinated calves (Nos. 1 and 2) and 2 vaccinated calves
(Nos. 3 and 4), M. bovis was isolated from 12 of them
(27.3%) (Table 1). In 7 samples of 12 of these non-
inoculated, M. bovis-positive joints, histopathological
changes were seen while the samples from the other 5M.
bovis-positive joints were histologically unremarkable.
From samples of 9 non-inoculated joints of the 4 calves
with histopathological changes no M. bovis organisms or
other bacteria were isolated (Tables 1 and 2).
The subsynovial connective tissue of the inoculated
right carpal joint of all 4 calves had multifocal, variable
sized, irregularly formed caseonecrotic foci (Table 2).
Such lesions were also found in the subsynovial connect-
ive tissue of 2 additional joints of calf No. 1 and in an
additional joint of calf No. 2 (Table 2). Caseonecrotic
foci were infiltrated with numerous morphologically in-
tact and degenerate neutrophilic granulocytes (Figure 1).
In the periphery of the foci many macrophages and fewer
numbers of lymphocytes and plasma cells were found.
There was multifocal slight hypertrophy and hyperplasia
of synovial lining cells. Within the upper and deeper
subsynovial tissue mainly perivascularly located accu-
mulations of few lymphocytes and moderate numbers of4 calves after intra-articular inoculation/challenge with
Left fore limb Right hind limb Left hind limb
A1 B1 C1 A2e B2f C2g A2 B2 C2
+ + + - + - - + +
- - - - - - - - -
- - - + - + - - +
- + - - - - - - -
Table 2 Histopathological findings in 4 calves after intra-articular inoculation/challenge with Mycoplasma bovis
Calf no. Necropsy after
inoculation/challenge (in days)
Right fore limb Left fore limb Right hind limb Left hind limb
A1a B1b,c C1d A1 B1 C1 A2e B2f C2g A2 B2 C2
1h 12 +j Nk,+++l -m - ++n N,+++ + ++ - - N,+++ -
2h 14 - N,+++ + - + N,+ + + - + + -
3i 10 - N,+++ nao - na na ++ na + - na -
4i 12 - N,+++ na na - na na + na na - na
aelbow joint. bcarpal joint. cinoculated joint. dmetacarpo-phalangeal joint.
efemoro-tibial joint. ftarsal joint. gmetatarso-phalangeal joint.
hnon-vaccinated animal. ivaccinated animal.
jmild inflammatory cell infiltration. knecrosis. lmarked inflammatory cell infiltration.
mno abnormalities detected.
nmoderate inflammatory cell infiltration.
ono sample available.
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sue samples from the control calf were histologically
unremarkable.
M. bovis antigens were exclusively found in necrotic
tissue areas. M. bovis antigens were detected in the cyto-
plasm of macrophages and neutrophilic granulocytes de-
marcating the necrotic foci both with the polyclonal
antibody D490 and with the mAb pool. Antigens were
also found extracellularly within and especially at the
periphery of necrotic tissue areas (Figure 2). With mAb
1A1 in all tissue sections with necrotic foci a similar la-
belling pattern was seen, although less antigen was
present than in sections immunolabelled with antibody
D490 and the mAb pool. With mAb 1E5 positive immu-
nolabelling was only found in the necrotic lesions of the
inoculated right carpus of calf No. 2.
Immunohistochemical phenotyping of inflammatory
cells revealed that the majority of macrophages located
within and especially at the periphery of caseonecroticTable 3 Antibodies used in this study




mAbb pool Mouse IgG and IgM M. bovis
1A1 Mouse IgG1 M. bovis VspA, C, and other
1E5 Mouse IgM M. bovis VspA, B, C
Anti-CD3 Rabbit IgG CD3+ T lymphocytes
BAQ44A Mouse IgM B lymphocytes
Anti-MRP8 (S100A8) Mouse IgG Human MRP8e
Anti-MRP14 (S100A9) Mouse IgG Human MRP14g
TAL.1B5 Mouse IgG1 α-chain of human
leukocyte antigen (HLA-DR)
Anti-iNOS/NOS II Rabbit IgG iNOS
Anti-NT Rabbit IgG NT
aFluka, Buchs, Switzerland. bmonoclonal antibody. cvariable surface proteins belong
dBIOLOGO, Kronshagen, Germany. eCalgranulin A fVWR TM International GmbH, Darlesions were expressing S100A8 (Figures 3 and 4) and
S100A9 (not shown). In the periphery of necrotic foci
and around blood vessels within the deeper subsynovial
tissue few T and B lymphocytes were present (not
shown). MHC class II expression was found on approxi-
mately 10–20% of synovial lining cells and on many lym-
phocytes, macrophages and cells resembling dendritic
cells located perivascularly within the non-necrotic con-
nective tissue of synovial membranes (not shown). Mac-
rophages in perinecrotic areas only occasionally were
positive for MHC class II (Figure 5). Numerous macro-
phages demarcating the necrotic foci and also macro-
phages located perivascularly in the surrounding synovial
tissue had cytoplasmic expression of iNOS (Figure 6
and 7) and NT. Such immunolabelling was occasionally
seen in neutrophilic granulocytes in the periphery of
necrotic lesions. Sections from the control calf were nega-
tive for M. bovis antigen and had approximately 10–20%
MHC II-positive synovial lining cells. Furthermore, singleDilution Antigen retrieval References/source
1:1800 0.25% trypsina (37°C, 60 min) [26]
1:2000 0.25% trypsin (37°C, 60 min) Chemicon
Vspsc 1:200 0.25% trypsin (37°C, 60 min) [27]
undiluted 0.25% trypsin (37°C, 60 min) [26,28,29]
1:300 Demasking solution Gd (95°C, DakoCytomation
1:100 20 min) 0.01 M citric buffer
(microwave 95°C, 10 min)
VMRD; [23]
1:600 Pronase Ef (37°C, 20 min) [26], BMA Biomedicals; [30]
1:8000 0.01 M citrate buffer
(microwave 95°C, 10 min)
BMA Biomedicals; [30]
1:4000 0.01 M citrate buffer
(microwave 95°C, 15 min)
DakoCytomation
1:50 Saponinef (37°C, 20 min) [31,32]; Biomol GmbH
1:100 Pronase E (37°C, 20 min) Millipore GmbH
ing to the Vsp protein family of M. bovis.
mstadt, Germany. gCalgranulin B.
Figure 3 Immunohistochemistry of a caseonecrotic lesion in
the subsynovial connective tissue for S100A8 (MRP8). The
necrotic centre (N) is demarcated by numerous S100A8-expressing
phagocytes. The frame identifies an enlarged area presented in
Figure 4. ×100.
Figure 1 Caseonecrotic lesion in the subsynovial connective
tissue. The necrotic centre (N) is demarcated and infiltrated by
numerous neutrophilic granulocytes and macrophages. Left
metacarpo-phalangeal joint of calf No. 1. H&E. ×200.
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both S100A8 and S100A9 were found in perivascular areas
of sections from the control animal.
Discussion
In this investigation, joint tissue samples from 4 calves,
i.e. 2 vaccinated and 2 non-vaccinated, which were part
of a vaccination experiment, were examined after intra-
articular challenge with M. bovis for characterizing the
histopathological findings including the types of inflam-
matory cells, MHC class II expression, the distribution
of Vsp antigens of M. bovis, and the expression of
markers for nitritative stress, i.e. iNOS and NT.
In all 4 calves, inoculation of M. bovis strain 1067 not
only induced necrotizing and inflammatory lesions
within their inoculated right carpal joint, but also re-
sulted in necrotic and/or inflammatory lesions in several
non-inoculated joints of the fore and/or hind limbs. TheFigure 2 Immunohistochemistry for Mycoplasma bovis antigen
in an area of necrosis (N) with numerous macrophages with
cytoplasmic antigen. Right carpal joint of calf No. 2. Polyclonal
antibody D490. ABC method. Chromogen DAB. ×400.lesions within the synovial membranes were associated
with the presence of the agent as demonstrated by im-
munohistochemistry and reisolation by cultivation. M.
bovis antigens including Vsp antigens were still present
at 10 and 14 days after infection and were exclusively
found within caseonecrotic lesions, i.e. in the inoculated
joints of all 4 calves and in 3 additional non-inoculated
joints of 2 of the 4 calves.
The results of this investigation show that the necro-
tizing foci, as in lungs of infected calves [6,7], are the
main reservoir for M. bovis although they are demarcated
and infiltrated by numerous neutrophilic granulocytes and
macrophages. Furthermore, the presence of Vsp antigens
both in the cytoplasm of macrophages and extracellularly
as detected with the monoclonal antibodies 1A1 and 1E5Figure 4 A higher magnification of Figure 3 shows that the
majority of macrophages have strong immunohistochemical
labelling of the cytoplasm. Left metacarpo-phalangeal joint of calf
No. 1. ABC method. Chromogen DAB. ×400.
Figure 7 A higher magnification of Figure 6 shows numerous
macrophages with strong cytoplasmic immunolabelling. Left
metacarpal-phalangeal joint of calf No. 1. ABC method. Chromogen
AEC. ×400.
Figure 5 Immunohistochemistry for MHC class II in a necrotic
area in the subsynovial tissue. There are only single MHC II-positive
macrophages (arrows) surrounding the necrosis (N). Left metacarpal-
phalangeal joint of calf No. 1. ABC method. Chromogen DAB. ×400.
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there is in vivo expression of M. bovis Vsp antigens. Vari-
able expression of these proteins may be a major mechan-
ism by which M. bovis evades the host immune response.
The vaccination experiment was performed to evaluate
the potential effects of a formalinized vaccine for pre-
vention of M. bovis arthritis. A protective effect of the
vaccine preventing spreading of M. bovis from the inoc-
ulated joint to non-inoculated joints was not found. Cul-
tural isolation revealed that M. bovis organisms, in
addition to the 4 inoculated joints, were also present in
approximately 27% of 44 non-inoculated joints. Statisti-
cally significant differences in the number of infected
joints after challenge with M. bovis between vaccinated
and non-vaccinated calf groups were not detected [11].
Furthermore, histopathology on the joint samples fromFigure 6 Immunohistochemistry of a necrotic area (N) in the
subsynovial tissue for iNOS. The necrotic lesion is surrounded by
numerous iNOS-positive phagocytes. The frame identifies an enlarged
area presented in Figure 7. ×100.the 4 calves performed in this study did not reveal any
differences in extent or severity between the lesions in
the 2 vaccinated and the 2 non-vaccinated animals.
Studies in M. bovis-infected calves with pneumonia
suggest that they subsequently develop arthritis resulting
from invasion across the airway or alveolar epithelium,
or by lymphatic drainage from alveoli through the inter-
alveolar septa [1,2]. The results of this investigation
show that M. bovis, after initial infection of joint tissue
at the inoculation site, subsequently must have spread to
other joints most likely by entering the circulation via
blood and/or lymphatic vessels. Taking into account the
findings of other investigators [15] it seems possible that
the agent, after entering the circulation, actively may
have invaded peripheral blood mononuclear cells or may
have been phagocytosed by such cells and thereafter was
transferred to other joints.
The caseonecrotic lesions in the subsynovial connective
tissue of the calves histologically closely resemble caseone-
crotic foci occurring in lungs of calves after spontaneous
or experimental infection [2,3,7]. The pathogenetic mech-
anisms leading to the development of these necrotizing le-
sions are largely unknown. Findings in lungs of calves
with caseonecrotic pneumonia suggest that they mainly
occur when other pathogenic bacteria, e.g. Trueperella
pyogenes, Pasteurella multocida, and Staphylococcus aur-
eus, are present [7,16,17]. In this study, from joints of ani-
mals with necrotizing lesions, however, no other bacteria
than M. bovis were cultured. This strongly indicates that,
at least in the joints, the organism itself and/or certain fac-
tors or mediators possibly produced by macrophages, neu-
trophilic granulocytes and other inflammatory cells are
able to induce these necrotizing lesions.
Immunohistochemical findings in pneumonic lung tis-
sue of M. bovis-infected calves suggest that nitrogen
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monary lesions [6,8]. Necrotizing lesions in the lungs of
M. bovis-infected calves are characterized by persistence
of M. bovis antigens including Vsp antigens and the
presence of numerous macrophages expressing iNOS
and NT [6]. In general, iNOS is mainly synthesized by
activated macrophages following stimulation by different
factors, e.g. bacteria, bacterial components such as lipo-
polysaccharides (LPS), and cytokines, and leads to the
production of nitric oxide (NO) from L-arginine. The
damaging effects of NO are mediated by peroxynitrite
and can be demonstrated by the detection of NT [18–20].
As described for the lungs of calves with caseonecrotic
pneumonia [6] the necrotic foci in the joints were de-
marcated by numerous macrophages strongly express-
ing iNOS and NT indicating production of NO and
peroxynitrite.
In vitro studies with human and bovine articular cartil-
age explants have shown that the induction of NO acti-
vates matrix metalloproteinases (MMPs) [21]. Possibly,
NO produced by macrophages and/or cytokines (IL-1,
TNF-α) in inflamed M. bovis-infected joints activates
MMPs leading to collagen breakdown and destruction of
joint tissue. Furthermore, cytokines or MMP’s produced
by activated synoviocytes and mononuclear inflamma-
tory cells could be involved in this destructive process.
The results of this study show that, in spite of the de-
veloping local immune response of the host, i.e. the de-
marcation of necrotic foci by numerous phagocytes and
other inflammatory cells, M. bovis antigens as well as vi-
able organisms are able to persist within caseonecrotic
tissue lesions. As in necrotizing lung lesions [6,7] only
single macrophages demarcating the necrotic synovial
lesions in calves of this study were positive for MHC
class II antigen. This finding suggests that down-regulation
of antigen-presenting mechanisms occurs which possibly is
caused by marked local production of iNOS and NO by in-
filtrating macrophages.
The antibodies used in this study for immunolabelling
of macrophages detect calprotectin, which is a heterodimer
of two calcium-binding proteins. Calprotectin is present in
the cytoplasm of neutrophilic granulocytes and reactive tis-
sue macrophages and is secreted extracellularly from stim-
ulated cells or is released as a result of cell disruption or
death [22]. Calprotectin is known under several synonyms
(complex of S100A8 and S100A9 proteins, macrophage in-
hibitory factor-related protein MRP8/14, L1L and L1H
proteins, calgranulin A/B) and can be induced in human
monocytes by certain cytokines (IL-1β, TNF-α) and by
LPS. Calprotectin is produced by freshly recruited, classic-
ally activated, pro-inflammatory subtypes of macrophages
in tissue of different species including cattle [22–24] but
can also be induced by IL-10 during later stages of inflam-
mation. In this study, low expression of MHC class II bymacrophages demarcating the necrotic tissue areas
within the joint tissue indicates that these macrophages,
possibly under the influence of certain cytokines pro-
duced during inflammation, e.g. IL-1 and IFN-γ, are in a
stage of diminished activation as discussed for ma-
crophages demarcating necrotic foci in lungs of M.
bovis-infected calves [7]. Recent investigations in bovine
macrophages, however, revealed that the results of the
mere expression of calprotectin detected by immuno-
histochemistry cannot be used to characterize the func-
tionality of macrophages in bovine tissue [25]. Further
studies are needed to characterize the phenotypes and
the functional characteristics of macrophages involved
in necrotic and inflammatory lesions in joint and lung
tissue of M. bovis-infected calves.
Conclusions
The results of this study demonstrate that M. bovis, fol-
lowing infection of a joint spreads to other joints causing
necrotizing and inflammatory changes. The findings that
the presence of M. bovis antigens in necrotic foci is asso-
ciated with marked local production of iNOS and NT
strongly suggest that in the development of these joint
lesions nitritative injury is involved as in necrotizing
lung lesions of M. bovis- infected calves. Also, the results
of this study revealed that, as in pneumonic animals, M.
bovis is evading the immune response and that the re-
sponses both in vaccinated and non-vaccinated calves do
not protect them from the development and spread of
arthritic lesions. Further investigations are needed to
study the interference of M. bovis with the specific and
innate immune responses of the host.
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